Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...

A UF study finds that two common diabetes drugs may help protect against Alzheimer’s disease in older adults with Type 2 ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

For residents of rural North Carolina, quality health care can seem nonexistent. Let alone affordable. Now, one of the only ...

Polypharmacy is associated with poor clinical outcomes following COVID-19 infection among patients with type 2 diabetes.

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide ...

In an hour-long meeting at Eli Lilly and Company’s headquarters in Indianapolis on April 15, the pharmaceutical company’s top ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

Spending on Ozempic, Wegovy and other similar prescriptions soared 500 percent in five years, according to a research letter.

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...